Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandoz Mesalamine vs Canasa in Ulcerative Proctitis
NCT01172444Phase 3Terminated
- Sponsor
- Sandoz
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Salcrozine in ulcerative proctitis (3 arms), sponsored by Sandoz. Primary endpoint: Disease Activity Index at 6 weeks. Started Jun 2010; status: terminated.
02
Drugs
Salcrozine
03
Conditions
ulcerative proctitis
Beyond the preview
Go deeper on NCT01172444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172444.